Header Logo

Connection

Mark Schmidt to Middle Aged

Back to Details
This is a "connection" page, showing publications Mark Schmidt has written about Middle Aged.
Mark Schmidt
Connection Strength
0.792
Middle Aged
  1. Economic Burden of Acute Gastroenteritis among Members of Integrated Healthcare Delivery System, United States, 2014-2016. Emerg Infect Dis. 2024 May; 30(5):968-973.
    View in: PubMed
    Score: 0.102
  2. Herpes zoster diagnosis and treatment in relation to incident dementia: A population-based retrospective matched cohort study. PLoS One. 2024; 19(1):e0296957.
    View in: PubMed
    Score: 0.100
  3. A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system. PLoS One. 2018; 13(8):e0201805.
    View in: PubMed
    Score: 0.068
  4. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010 Nov 16; 28(49):7713-5.
    View in: PubMed
    Score: 0.040
  5. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol. 2021 01; 55(1):77-83.
    View in: PubMed
    Score: 0.020
  6. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun. 2021 03; 5(3):400-411.
    View in: PubMed
    Score: 0.020
  7. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. 2020 May 22; 369:m1923.
    View in: PubMed
    Score: 0.019
  8. Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. Am J Gastroenterol. 2020 02; 115(2):262-270.
    View in: PubMed
    Score: 0.019
  9. Mental and physical health status among chronic hepatitis B patients. Qual Life Res. 2020 Jun; 29(6):1567-1577.
    View in: PubMed
    Score: 0.019
  10. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure. J Viral Hepat. 2019 10; 26(10):1210-1217.
    View in: PubMed
    Score: 0.018
  11. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019 03 05; 68(6):956-963.
    View in: PubMed
    Score: 0.018
  12. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
    View in: PubMed
    Score: 0.018
  13. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Aliment Pharmacol Ther. 2019 03; 49(5):599-608.
    View in: PubMed
    Score: 0.018
  14. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018 06; 32(2):253-268.
    View in: PubMed
    Score: 0.017
  15. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States. Gastroenterology. 2018 02; 154(3):754-758.
    View in: PubMed
    Score: 0.016
  16. A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C. Dig Dis Sci. 2017 11; 62(11):3221-3234.
    View in: PubMed
    Score: 0.016
  17. Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution. Dig Dis Sci. 2017 10; 62(10):2704-2712.
    View in: PubMed
    Score: 0.016
  18. Changing trends in complications of chronic hepatitis C. Liver Int. 2018 02; 38(2):239-247.
    View in: PubMed
    Score: 0.016
  19. Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017 Jun; 32(6):1250-1257.
    View in: PubMed
    Score: 0.016
  20. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study. Dig Dis Sci. 2016 12; 61(12):3469-3477.
    View in: PubMed
    Score: 0.015
  21. Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. Clin Infect Dis. 2016 11 01; 63(9):1205-1208.
    View in: PubMed
    Score: 0.015
  22. Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Dig Dis Sci. 2016 07; 61(7):2087-93.
    View in: PubMed
    Score: 0.015
  23. Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012-2013. PLoS One. 2016; 11(4):e0148395.
    View in: PubMed
    Score: 0.015
  24. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma. J Viral Hepat. 2016 09; 23(9):718-29.
    View in: PubMed
    Score: 0.015
  25. Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection. Clin Gastroenterol Hepatol. 2016 07; 14(7):1044-1055.e3.
    View in: PubMed
    Score: 0.014
  26. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus. Clin Infect Dis. 2016 Feb 01; 62(3):289-297.
    View in: PubMed
    Score: 0.014
  27. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study. Am J Gastroenterol. 2015 Aug; 110(8):1169-77; quiz 1178.
    View in: PubMed
    Score: 0.014
  28. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention. Hepatology. 2015 May; 61(5):1479-84.
    View in: PubMed
    Score: 0.014
  29. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology. 2015 Mar; 61(3):802-11.
    View in: PubMed
    Score: 0.013
  30. Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort. Clin Infect Dis. 2015 Feb 15; 60(4):514-22.
    View in: PubMed
    Score: 0.013
  31. Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS). J Community Health. 2014 Oct; 39(5):914-21.
    View in: PubMed
    Score: 0.013
  32. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014 Dec; 21(12):917-20.
    View in: PubMed
    Score: 0.013
  33. Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin Infect Dis. 2014 Oct; 59(7):976-81.
    View in: PubMed
    Score: 0.013
  34. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014 Dec; 21(12):930-7.
    View in: PubMed
    Score: 0.012
  35. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010 Jan 15; 50(2):184-91.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente